WP1 Management and Investments
Management, coordination, development of the organization and coordination of investments.
- Organizing leader group meetings and reports on Biobank Norway to the Research Council of Norway (RCN) and other stakeholders
- Participates actively in the European biobank infrastructure BBMRI-ERIC and other international biobank initiatives
- Organizing national and international conferences on biobanking
- Communicates actively with the public and biobank donors through our web site and other initiatives
- Investments; automated -80 storage at Oslo University Hospital
WP2 Integrated model for precision medicine
Deliverables:
- Establish a joint national strategic interest forum and an operational team coordinating the activities of partners related to the 'use case'
- Select, plan and design representative 'use cases' for personalized medicine using population and clinical biobanks, and integrate these with registries and clinical data
- Develop a common data management policy in collaboration with and approved by all partner institutions
- Establish an integrated infrastructure that utilizes biobanks for research in personalized medicine using 'use cases'
- Test and improve infrastructure using personalized medicine use cases and develop Standard Operating Procedures (SOP)
WP3 Clinical biobanks
Deliverables:
- Establishment of four working groups
- Build hospital based general biobanks bridging regional boundaries
- Establish biobanking within community health care
- Develop possibilities for industry collaboration with clinical biobanks established in BN3
- Clarify legal and ethical challenges for hospital based research biobanks
WP4 HAP-integration and Researcher Support
Deliverables:
- Organize a help desk for project oriented analysis support
- Workshop/course in large-scale data-management and analysis
- Assist HAP in developing a cohort explorer based on use-cases developed in WP2
- Ensure that the development of HAP meets the needs of biobank researchers
- Develop procedures and solutions for data sharing through a Norwegian EGA node
- Relevant tools for large-scale analysis, analysis of "rare-variants" and statistical power
WP5 Digital biobanking
Deliverables:
- Establish networks for "value management" of digital biobank data
- Develop frameworks for valuation / management of data adapted to digital biobank data
- Guidelines for the storage and handling of digital tissue images in biobank archives (digital pathology)
- Guidelines for storing and handling digital gene samples and other large-scale biobank archive datasets
- Data Import Guidelines from Digitizer, Data Export Guidelines for Large Digital Biobank Samples
CS1 Quality Biobanking
Common Service Biobanking has established a biobank help desk, and organizes disseminated services such as:
- Sample handling
- Quality management
- Technical solutions
- Lab ware
- DNA and RNA extraction, quality studies
- LIMS/Data base solutions
- Biobank constructions/establishments
- Energy consumption and recycling
CS2 ELSI
Hva gjør vi?
- Vi bidrar til å sikre optimal bruk av norske forskningsbiobanker med en høy etisk standard
- Vi arbeider for å fremme offentlig engasjement rundt bruken av norske biobanker
- Vi bidrar til at arbeidet i Biobank Norge utøves i tråd med juridiske og samfunnsmessige krav
- Vi rådgir biobankforskere og institusjoner i forhold til etiske utfordringer
- Vi utvikler verktøy, retningslinjer og informasjonsmateriell som hever bevisstheten om viktige etiske utfordringer ved biobankforskning
- Vi undersøker forskeres og deltakeres holdninger til etiske spørsmål ved biobankvirksomhet
Hvilke sentrale spørsmål er vi opptatt av?
- Bør biobankdeltakere gis anledning til å få tilgang til individuelle genetiske forskningsdata?
- Hvordan bør en beskytte personvernet til biobankdeltakerne når data deles med forskningsmiljøer i andre land?
- Hvilken etiske utfordringer dukker opp ved et tettere samarbeid mellom offentlige forskningsbiobanker og legemiddelindustrien?
- Hvilken rolle bør biobankdeltakerne ha i å påvirke utforming og gjennomføring av forskningsstudier?
- Hvordan utvikle samtykke- og kommunikasjonsformer som sikrer deltakernes interesser og gir god forskning?